BB50255: Medical biotechnology
[Page last updated: 15 October 2020]
![]() | 2020/1 |
![]() | Department of Biology & Biochemistry |
![]() | 15 [equivalent to 30 CATS credits] |
![]() | 300 |
![]() | Masters UG & PG (FHEQ level 7) |
![]() |
|
![]() | CW 50%, EX 50% |
![]() |
|
![]() |
|
![]() | |
Description: | Aims: This unit is aimed at students interested in analysing the strengths and limitations of proteomic technologies and the application of structural biology data in medicine. Learning Outcomes: By the end of this unit you will be able to: * Demonstrate a critical and integrated overview of the key processes controlling the production and turnover of cellular proteins; * Evaluate and analyse the strengths and limitations of proteomic technologies and application of structural biology data in medicine; * Critically evaluate the wider applications of enzymes in biotechnology & medicine; * Examine the impact of genome sequencing and recombinant DNA technologies on the potential application of enzymes in medicine; * Communicate your critical evaluation and analyses through a formal presentation. Content: Topics include protein folding, post-translational modifications and turnover, computational approaches to proteomics, enzyme engineering; biosensors; enzyme chaperones; clinical enzymology; enzyme therapy; enzymes as target for drugs; catalytic antibodies; extremozymes. |
![]() |
BB50255 is Optional (DEU) on the following programmes:Department of Biology & Biochemistry
|
Notes:
|